Equities

Deversify Health AB (publ)

Deversify Health AB (publ)

Actions
  • Price (EUR)0.0002
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change-97.72%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2.294.8112
Total Receivables, Net3.043.564.29
Total Inventory0.280.44--
Prepaid expenses0.200.710.82
Other current assets, total------
Total current assets5.819.5217
Property, plant & equipment, net00.140.11
Goodwill, net--1520
Intangibles, net101113
Long term investments--00.03
Note receivable - long term00.370.35
Other long term assets------
Total assets163650
LIABILITIES
Accounts payable3.754.593.47
Accrued expenses1.812.202.44
Notes payable/short-term debt01.711.19
Current portion long-term debt/capital leases------
Other current liabilities, total2.814.117.77
Total current liabilities8.361315
Total long term debt000
Total debt01.711.19
Deferred income tax------
Minority interest00.00--
Other liabilities, total7.192.801.12
Total liabilities161516
SHAREHOLDERS EQUITY
Common stock--1.2722
Additional paid-in capital------
Retained earnings (accumulated deficit)--(13)(12)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.283224
Total equity0.282134
Total liabilities & shareholders' equity163650
Total common shares outstanding625428
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.